The issue: Pfizer has announced a shortage of the LifeShield™ calcium chloride 100 mg/mL (10%) X 10 mL pre-filled syringes (PFS) and will soon be unable to meet NH usage requirements.
Newsroom
The issue: Pfizer has issued a voluntary recall of several lots of propranolol extendedrelease capsules (Inderal-LA®; 60 mg, 80 mg, 120 mg, and 160 mg strengths) due to the presence of impurity N-nitroso-propranolol above the acceptable concentration limit.
The Issue: Due to the shortage of Canadian-labelled hydralazine 20 mg/mL X 1 mL vials from SteriMax, Health Canada has authorized the importation of a US-labelled product. NH pharmacy will soon have supply of this USlabelled product available for use in NH facilities.
The issue: Methotrimeprazine 25 mg/mL x 1 mL injectable is a single source item from Sanofi-Aventis who has indicated the drug is not currently available to order.
Resolution: The shortage of sodium phosphate 3 mmol/mL injection has resolved and NH pharmacy now has access to an adequate ongoing supply.
The Issue: Due to unprecedented demand for propofol across Canada throughout the waves of the COVID-19 pandemic, Health Canada previously approved the importation of US-labelled propofol 10 mg/mL X 100 mL vials from Sagent Pharmaceuticals (Omega) as a national safety stock.
The issue: EPINEPHrine 1 mg/10 mL pre-filled syringes (PFS) are in short supply from the sole source vendor in Canada (Pfizer) and likely to go on backorder soon. NH has approximately 5 to 6 weeks of stock in pharmacies and available as wardstock.